Krawczyk, N., Bandara, S., Merritt, S., Shah, H., Duncan, A., McEntee, B., Schiff, M., Ahmad, J., Whaley, S., Latimore, A., & Saloner, B. (2022). Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative. Addiction science & clinical practice, 17(1), 30. https://doi.org/10.1186/s13722-022-00313-6 

https://pubmed.ncbi.nlm.nih.gov/35655293/ 

This study surveyed and interviewed 11 correctional facilities to learn about the barriers and facilitators of MOUD at their facilities. Barriers discussed included limited funding and resources (especially for methadone treatment), bail reform leading to shorter jail stays, and lack of community resources which leads to difficulty coordinating continuing treatment. Facilitators discussed included expediting the intake process or beginning it earlier, giving bridge prescriptions, establishing relationships with community treatment programs and taking a person-centered approach to understanding diversion when it occurs. COVID-19 led to the inclusion of telehealth in some facilities. 

Bottom Line: Surveys and qualitative interviews with 11 correctional facilities were conducted to gain insight into barriers and facilitators that effect MOUD treatment in correctional facilities, including funding, unpredictable lengths of stay, limited community resources, improving the intake process, giving bridge prescriptions, and establishing relationships with community treatment programs.